Humoral immune responses to gag and env proteins from human immunodeficiency virus type 1 in hemophiliac patients (original) (raw)

1991, American Journal of Hematology

Abstract

Solid-phase enzyme immunoassays using recombinant gag and env proteins were developed to study humoral immune responses to HIV infection in a cohort of 105 hemophiliac patients. Thirteen patients with ARC or AIDS and 92 asymptomatic patients were studied. A cross-sectional study showed a wide range of antibody responses to gag and env proteins; however, the differences between the ARC/AIDS and asymptomatic patients were statistically significant for both antigens (P < .0004). In a longitudinal study, antibody levels in sera from 11 asymptomatic patients with gag antibody log units 4. 5 were compared to levels in sera from 10 ARC/AIDS patients and 8 asymptomatic patients with gag antibody >1.5. These patient groups were followed for comparable periods of time (67.1-71.7 mo). The asymptomatic patients with low gag antibody and the ARC/AIDS patients showed a similar pattern of antibody response to gag protein overtime. In hemophiliac patients with HIV-1 infection a low titer of antibody to gag protein is not invariably associated with clinical deterioration and is not a useful serologic marker of impending progression to AIDS.

Loading...

Loading Preview

Sorry, preview is currently unavailable. You can download the paper by clicking the button above.

References (29)

  1. Elster ME. Gail MH, Ballard JO, et al.: Natural history of human immunodeficiency virus infections in hemophiliacs: Effects of T-cell sublets. platelet counts, and age. Ann Intern Med 107:1, 1987.
  2. Allain JP. Laurian Y. Paul DA, et al.: Long-term evaluation of HIV antigen and antibodies to p24 and gp41 in patients with hemophilia: Potential clinical importance. N Engl J Med 317:1114, 1987.
  3. Weber JN. Weiss RA, Roberts C. et a].: Human immunodeficiency virus infections in two cohorts of homosexual men: Neutralizing sera and association of anti-gag antibody with prognosis. Lancet i: 119, 1987. Pedersen C. Moiler Nielsen C, et al.: Temporal relation to antige- nacniia and loss of antibodies to core antigens to development of clinical disease in HIV infection. Br Med J [Clin Res] 295567, 1987. Schmidt G. Amiraian K, Frey H, et al.: Densitometric analysis of western blot (immunoblot) assays for human immunodeficiency virus antibodies and correlation with clinical status. J Clin Microbiol 25:1993. 1987.
  4. Goudsmit J. Lange JMA. Paul DA, Dawson GJ: Antigenemia and antibody titers to core and envelope antigens in AIDS, AIDS-related complex and subclinical human immunodeficiency virus infection. J Infect Dis 155558, 1987.
  5. Cao Y . Valentine F, Hojvat S, et al.: Detection of HIV antigen and specific antibodies to HIV core and envelope proteins in sera of patients with HIV infection. Blood 70575, 1987.
  6. Pan L-Z, Cheng-Mayer C, Levy JA: Patterns of antibody responses in individuals infected with the human immunodeficiency virus. J Infect Dis 155:626, 1987.
  7. Groopman JE, Chen FW, Hope JA, et al.: Serological characi.erization of HTVL-I 11 infection in AIDS and related disorders. J Infect Dis 153:736, 1986.
  8. McDougal JS, Kennedy MS, Nicholson JKA, et al.: 4ntibody response to human immunodeficiency virus in homosexual men: Relation of antibody specificity, titer, and isotype to clinical status, severity of immunodeficiency, and disease progression. J Clin Invest 80:316, 1987.
  9. Mayer KH, Falk LA, Paul DA, et al.: Correlation of enzyme-linked immunosorbent assays for serum human immunodeficiency virus antigen and antibodies to recombinant viral proteins with subsequent clinical outcomes in a cohort of asymptomatic homosexual men. Am J Med 83:208, 1987.
  10. Polk, BF, Fox R, Brookmeyer R, et al.: Predictors of the acquired immunodeficiency syndrome developing in a cohort of seropositive homosexual men. N Engl J Med 316:61, 1987.
  11. deWolf F, Lange SMA, Houweling JTM, et al.: Numbers of C D 4 t cells and the levels of core antigens of and antibodies to the human immunodeficiency virus as predictors of AIDS among seropositive homosexual J Infect Dis 158:615, 1988.
  12. AIDS-Hemophilia French study Group: Natural history of primary infection with LAV in multitransfused patients. Blood 6839, 1984.
  13. Hilgartner MW: AIDS in the transfused patient. Am J Dis Child 141:194, 1987.
  14. Redfield RR, Wright DC, Tramont EC: The Walter Reed staging classification for HTLV-IIIILAV infection. N Engl J Med 314: 131, 1986.
  15. Ratner L, Haseltine W, Patarca R, Livak KJ, Starcich B, Josephs SF, Doran ER, Rafalski JA, Whitehorn EA, Baumeister EL, et al.: Complete nucleotide sequence of the AIDS virus, HTLV-111. Nature 313:277, 1985.
  16. Bishop PC, Boone D, Parker JW: Immunophenotypes by flow cytometry: a longitudinal study in healthy individuals. Diagn Clin Immunol 5:232, 1988.
  17. Fletcher MA, Azen SP, Adelsberg B, et al.: lmmunophenotypes in a multicenter study: the Transfusion Safety Study experience. Clin Imniuno Immunopathol 52:38, 1989.
  18. Fletcher MA, Baron GC, Ashman MR, et al.: Use of whole blood methods in assessment of immune parameters in immunodeficiency states. Diagn Clin Immunol 5:69, 1987.
  19. Reinhertz EL, Kung PC, Goldstein G, Schlossman SF: Separation of functional subsets of human T cells by a monoclonal antibody. Proc Natl Acad Sci USA 76:4061, 1979.
  20. Morimoto C, Letvin NL, Boyd AW, et al.: The isolation and characterization of the human helper inducer T cell subset. J Immunol 134:3762, 1985.
  21. Morimoto C, Letvin NL, Distaso JA, et al.: The isolation and characterization of the human supressor inductor T cell subset. J Immunol 134:1508, 1985.
  22. Nicholson JKA, Spira TJ, Aloisio CH, et al.: Serial determinations of HIV-1 titers in HIV-infected homosexual men: Association of rising titers with CD4 T cell depletion and progression to AIDS. AIDS Res. Hum. Reoviruses 5:205, 1989.
  23. deWolf F, Lamge SMA, Houweling JTM, et al.: Appearance of predictors of disease progression in relation to development of AIDS. AIDS 3563, 1989.
  24. Goudsmit J, de Wolf F, Paul DA, et al.: Expression of human immunodeficiency virus antigen in serum and cerbrospinal fluid during acute and chronic infection. Lancet 2:177, 1986.
  25. Spira T, Kaplan JE, Feorino PM, et a].: Human immunodeficiency virus viremia as a prognostic indicator in homosexual men with lymphadenopathy syndrome. N Engl J Med 317:1093, 1987.
  26. de Wolf F, Goudsmit J, Paul DA, et al.: Risk of AIDS related complex and AIDS in homosexual men with persistent HIV antigenaemia. Br Med J [Clin Res] 295569, 1987.
  27. Lange JMA, Paul DA, Huisman HG, et al.: Persistent HIV antige- naemia and decline of HIV core antibodies associated with transition to AIDS. Br Med J [Clin Res] 293:1459, 1986.
  28. Goedect JJ, Kessler CM, Aledort LM, et a].
  29. A prospective study of human immunodeficiency virus type I infection and the development of AIDS in subjects with hemophilia. N Engl J Med 321:1141, 1989.